Signal2026-07-24
ClinicalTrials.gov

[PHASE1] PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Part of

Advances In Cancer Treatment Protocols

Open primary sourceSee the whole picture